Fachliteratur Gastroenterologie: Neoplasien Pankreas

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Pankreas » Neoplasie

09. Mai 2026

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 2999


	Artikel 1 - 20 / 59975

	Redox-mediated activation of PI3K/PTEN pathways by A. baumannii OMV-V. myrtillus conjugate in pancreatic cancer cells. Arch Microbiol Celebi D, Baser S, Mahmoudnezhad A, Ari B, Celebi O, Genc S, Nigde E, Karabulut K, Taghizadehghalehjoughi A. PMID: 42101625 [PubMed - indexed for MEDLINE]
	Mortality and cancer incidence in a large cohort of lead-exposed workers. Int J Epidemiol Steenland K, Tan Y, Kelly-Reif K. PMID: 42101352 [PubMed - indexed for MEDLINE]
	Diagnosis and treatment of breast cancer during pregnancy: a comprehensive review. Front Med (Lausanne) Wei J, Qu F, Jiang T, Xu C. PMID: 42100272 [PubMed]
	Role of cancer-associated fibroblast-derived exosomes in pancreatic cancer: clinical therapeutic potential and targeting challenges. Front Immunol Hong W. PMID: 42099594 [PubMed - indexed for MEDLINE]
	Modified FOLFIRINOX with or Without Stereotactic Body Radiation in Locally Advanced Unresectable Pancreatic Cancer (SABER): A Randomized Open-Label Phase 2 Trial. Ann Surg Oncol Yoo C, Jeong H, Park I, Cheon J, Ryoo BY, Kim KP, Hwang DW, Song KB, Lee W, Kim SC, Song TJ, Oh D, Lee JS, Lee SS, Park JH. PMID: 42098550 [PubMed - as supplied by publisher]
	Pancreatic cancer. Nat Rev Dis Primers Roth S, Apte M, Balachandran VP, Biffi G, Conroy T, Cukierman E, Dotan E, Esposito I, Grünwald BT, Klauß M, Klein AP, Malats N, O Reilly EM, Pishvaian MJ, Real FX, Saur D, Siveke JT, Michalski CW. PMID: 42098138 [PubMed - indexed for MEDLINE]
	Genetic mutations governing ferroptosis sensitivity and resistance: a precision approach to cancer therapy. Cell Death Dis Tabnak P, Ebrahimnezhad M, HajiEsmailPoor Z. PMID: 42098074 [PubMed - as supplied by publisher]
	Comparison of outcomes of second-line durvalumab plus tremelimumab versus lenvatinib following first-line atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. PLoS One Nishioka C, Tahata Y, Maesaka K, Kai M, Shirai K, Murai K, Makino Y, Saito Y, Nozaki Y, Nakabori T, Ishida H, Yakushijin T, Iio S, Tatsumi N, Imanaka K, Kakita N, Sakamori R, Hosui A, Miyazaki M, Matsumoto K, Nakahara M, Doi Y, Sakakibara M, Hikita H, Kodama T, Takehara T. PMID: 42096473 [PubMed - indexed for MEDLINE]
	Applications of Celiac Plexus Block in Chronic Pancreatitis or Pancreatic Cancer. Curr Pain Headache Rep Ke X, Robinson CL, Liu H, Mei W, Shekoohi S, Kaye AD. PMID: 42096102 [PubMed - indexed for MEDLINE]
	Relationship Between Radiographic and Pathological Portal Vein-Superior Mesenteric Vein Involvement in Neoadjuvant Treatment for Pancreatic Cancer: A Comparative Study of Neoadjuvant Chemotherapy and Chemoradiotherapy. World J Surg Sekiguchi N, Takahashi H, Akita H, Sasaki K, Hasegawa S, Iwagami Y, Yamada D, Tomimaru Y, Asaoka T, Noda T, Shimizu J, Kobayashi S, Doki Y, Eguchi H. PMID: 42095757 [PubMed - as supplied by publisher]
	Clinical and molecular landscape of surgically resected early onset pancreatic cancer. Br J Surg Dreyer SB, Bryce A, Froeling F, Jackson S, Santana L, Dickson EJ, Coats M, McKay C, Holroyd D, Biankin AV, Jamieson NB, Chang DK. PMID: 42095609 [PubMed - indexed for MEDLINE]
	Vietnamese expert consensus on the treatment of hepatocellular carcinoma with transarterial chemoembolization. Front Radiol Luu VD, Tan DD, Thong PM, Khang LV, Dung LT, Binh LT, Trang NN, Cuong NN, Luan ND, Lam NL, Chau TH, Sy TV, Anh ND, Tho LD, Huy TD, Hieu DN, Son PQ, Tri LD, Huong ND, Phuong PC, Thinh NT, Thong VD, Phat HT, Duc PTH, Anh PG, Truc VHT, Trung LQ, Thao LB, Anh LT, Long TCD. PMID: 42095128 [PubMed]
	Clinical Prediction of Glycolysis-Driven Molecular Subclass of Hepatocellular Carcinoma without Transcriptomic Profiling. Liver Cancer Aoki T, Kudo M, Ogiso S, Okumura G, Hoshino M, Nakamura Y, Morisue R, Koyama S, Nishida N, Hanaoka K, Sakai K, Kurebayashi Y, Tsurusaki M, Morita M, Takebe A, Murase T, Kamei K, Matsumoto I, Nishio K, Nishikawa H, Hatano E. PMID: 42095119 [PubMed - as supplied by publisher]
	Emerging role of protein arginine methyltransferase 5 in gastrointestinal cancer (Review). Oncol Lett Zhang R, Lu Y, Fang X, Zhang F, Wu W, Song J, Liang Z. PMID: 42094816 [PubMed]
	Novel Efferocytosis-Related Prognostic Signature for Hepatocellular Carcinoma Patients Undergoing Transarterial Chemoembolization. Gut Liver Xie X, Zheng B. PMID: 42093115 [PubMed - as supplied by publisher]
	Two decades of PARP inhibitor synthetic lethality in cancer. Nature Lord CJ, Tutt ANJ, Ashworth A. PMID: 42092061 [PubMed - indexed for MEDLINE]
	Peritoneal cytology in pancreatic cancer: a comprehensive review on prognostic stratification and clinical decision-making. Cancer Metastasis Rev Wang R, Liu S, Ding J, Sun Y, Zhou J, Peng B, Wu Z. PMID: 42091747 [PubMed - indexed for MEDLINE]
	The emerging role of AXL in pancreatic cancer: Biomarker potential and therapeutic targeting to counteract drug resistance. Drug Resist Updat Immordino B, Rocco MA, Comandatore A, van der Zee G, Vahabi M, Morelli L, Giovannetti E. PMID: 42090760 [PubMed - as supplied by publisher]
	Optimizing bevacizumab exposure in atezolizumab-based therapy for unresectable hepatocellular carcinoma: A nationwide real-world study. Hepatology Aoe K, Tada T, Hiraoka A, Matono T, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Nishimura T, Tsuji K, Ishikawa T, Tajiri K, Tanaka H, Toyoda H, Ogawa C, Hatanaka T, Kakizaki S, Kawata K, Atsushi N, Kosaka H, Kuroda H, Yata Y, Nishikawa H, Imai M, Aoki T, Ochi H, Tamai H, Komatsu S, Matsuura T, Ueda Y, Kim SK, Ohama H, Tada F, Nakamura S, Nakamura Y, Yoshida O, Nouso K, Morishita A, Itokawa N, Okubo T, Arai T, Tsutsui A, Nagano T, Fukunishi S, Tanaka K, Koshiyama Y, Kanayama Y, Noritake H, Enomoto H, Matsui K, Kaibori M, Okamura J, Fukumoto T, Hiasa Y, Kudo M, Kumada T, RELPEC Group and HCC 48 Group. PMID: 42090542 [PubMed - as supplied by publisher]
	Integration of dual-energy CT characteristics and biomarkers: Noninvasive prediction of Ki-67 expression in pancreatic ductal adenocarcinoma. Med Phys Zhang W, Wang B, Shi D, Ruan Y, Cheng P, Ming S, Li M, Cao W, Wang M, Li J, Wei W. PMID: 42090202 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 59975

Seite 1 von 2999



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung